Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

PROCEPT BioRobotics (PRCT) EBT (2020 - 2025)

PROCEPT BioRobotics has reported EBT over the past 6 years, most recently at -$29.7 million for Q4 2025.

  • Quarterly results put EBT at -$29.7 million for Q4 2025, down 60.4% from a year ago — trailing twelve months through Dec 2025 was -$95.4 million (down 4.76% YoY), and the annual figure for FY2025 was -$95.4 million, down 4.76%.
  • EBT for Q4 2025 was -$29.7 million at PROCEPT BioRobotics, down from -$21.4 million in the prior quarter.
  • Over the last five years, EBT for PRCT hit a ceiling of -$12.8 million in Q1 2021 and a floor of -$29.7 million in Q4 2025.
  • Median EBT over the past 5 years was -$22.0 million (2022), compared with a mean of -$21.8 million.
  • Biggest five-year swings in EBT: crashed 65.75% in 2023 and later skyrocketed 32.58% in 2024.
  • PROCEPT BioRobotics' EBT stood at -$18.3 million in 2021, then tumbled by 35.79% to -$24.9 million in 2022, then decreased by 10.07% to -$27.4 million in 2023, then skyrocketed by 32.58% to -$18.5 million in 2024, then plummeted by 60.4% to -$29.7 million in 2025.
  • The last three reported values for EBT were -$29.7 million (Q4 2025), -$21.4 million (Q3 2025), and -$19.6 million (Q2 2025) per Business Quant data.